Press release
June 25, 2026
Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea
Incannex Healthcare Inc. (IXHL)
MELBOURNE, Australia and NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company developing innovative combination therapies for high-impact indications, today announced that the United States